LGALS3 and chronic obstructive pulmonary disease: The pooled results showed a significantly higher serum level of galectin-3 in patients with COPD compared to controls (standardized mean difference [SMD] 0.60; 95% confidence interval [CI] 0.40–0.80; P < 0.001; I2 ═ 68%).